ESC Congress 2025 Recap: 8 Trials to Know

Europe’s biggest stage for cardiovascular science once again delivered headline-making results in 2025. This year’s European Society of Cardiology (ESC) Congress showcased trials spanning the spectrum of cardiovascular subspecialties—from heart failure and hypertrophic cardiomyopathy to hypertension, lipid management, and triglyceride lowering. While some studies reinforced momentum for established therapies, others raised new questions or pointed toward emerging options that could reshape care.